Cargando…

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer

SIMPLE SUMMARY: In this survey study, we examined survey responses from 397 women with stage 0 to III unilateral breast cancer and found that partners, physicians, and the media were significant relative to the patient’s own influence in their decision to undergo a CPM. The findings of this study ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singareeka Raghavendra, Akshara, Alameddine, Hala F., Andersen, Clark R., Selber, Jesse C., Brewster, Abenaa M., Barcenas, Carlos H., Caudle, Abigail S., Arun, Banu K., Tripathy, Debu, Ibrahim, Nuhad K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123066/ https://www.ncbi.nlm.nih.gov/pubmed/33922702 http://dx.doi.org/10.3390/cancers13092050

Ejemplares similares

Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy
por: Davies, Kalatu R, et al.
Publicado: (2015)

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
por: Garber, Haven R., et al.
Publicado: (2022)

Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy
por: Agarwal, Shailesh, et al.
Publicado: (2020)

Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033)
por: Davies, Kalatu R., et al.
Publicado: (2016)

The Impact of Treatment for Smoking on Breast Cancer Patients’ Survival
por: Singareeka Raghavendra, Akshara, et al.
Publicado: (2022)

Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer
por: Wahlen, Madison M., et al.
Publicado: (2023)

Contralateral prophylactic mastectomy: current perspectives
por: Yao, Katharine, et al.
Publicado: (2016)

Abstract: Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies and Reconstruction
por: Schultz, Benjamin D., et al.
Publicado: (2018)

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
por: Elsayegh, Nisreen, et al.
Publicado: (2015)

Nationwide Trends in Contralateral Prophylactic Mastectomies: An Analysis of 55,060 Unilateral Breast Cancer Patients
por: Shaheen, Mohammed S., et al.
Publicado: (2022)

Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies
por: Mouabbi, Jason A., et al.
Publicado: (2022)

ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors
por: Mogol, Ayca, et al.
Publicado: (2022)

Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status
por: Baptiste, Dadrie F., et al.
Publicado: (2017)

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
por: Scheepens, Josien C.C., et al.
Publicado: (2021)

Abstract 9. Morbidity and Quality of Life Outcomes of Breast Reconstruction for Unilateral Mastectomy vs. Additional Contralateral Prophylactic Mastectomy: a Cohort Study of 211 Breast Reconstruction Patients Morbidity and Quality of Life Outcomes of Breast Reconstruction for Unilateral Mastectomy vs. Additional Contralateral Prophylactic Mastectomy: a Cohort Study of 211 Breast Reconstruction Patients
por: Sebai, Mohamad E., et al.
Publicado: (2017)

Trends in contralateral prophylactic mastectomy rate according to clinicopathologic and socioeconomic status
por: Jeon, Ho Jong, et al.
Publicado: (2019)

Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences
por: Makhnoon, Sukh, et al.
Publicado: (2022)

Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy
por: Venetis, Maria K., et al.
Publicado: (2018)

Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
por: Sciarra, Antonella, et al.
Publicado: (2021)

Abstract 4: Morbidity and Quality of Life Outcomes of Breast Reconstruction for Unilateral Mastectomy vs. Additional Contralateral Prophylactic Mastectomy: a Cohort Study of 211 Breast Reconstruction Patients
por: Sebai, Mohamad E., et al.
Publicado: (2017)

Immediate Implant-Based Reconstruction of the Contralateral or Bilateral Prophylactic Mastectomies: Risk Factor Analysis for Index and Prophylactic Breast
por: Dolen, Utku Can, et al.
Publicado: (2020)

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
por: van Sprundel, T C, et al.
Publicado: (2005)

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer
por: Elsayegh, Nisreen, et al.
Publicado: (2018)

Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer
por: Kim, Younji, et al.
Publicado: (2017)

Patient opinions on contralateral prophylactic mastectomy: A patient-driven discussion in need of tuning?
por: Brown, Zachary M., et al.
Publicado: (2022)

Preserving choice in breast cancer treatment: A different perspective on contralateral prophylactic mastectomy
por: Pender, Kelly, et al.
Publicado: (2023)

Trends in utilization of contralateral prophylactic mastectomy among different age, racial and ethnic groups
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation
por: Teoh, Victoria, et al.
Publicado: (2020)

Nomogram Predicts the Role of Contralateral Prophylactic Mastectomy in Male Patients With Unilateral Breast Cancer Based on SEER Database: A Competing Risk Analysis
por: Li, Kunlong, et al.
Publicado: (2021)

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
por: Schmidt, MK, et al.
Publicado: (2005)

Abstract 71: Postoperative Quality of Life in Patients Undergoing Contralateral Prophylactic Mastectomy with Breast Reconstruction
por: Rizzo, Amanda M., et al.
Publicado: (2018)

Clinical features, prognosis, and influencing factors of contralateral prophylactic mastectomy in 58 patients with breast cancer
por: Zheng, Yiqiong, et al.
Publicado: (2020)

Survival Outcomes in Patients With Hormone Receptor–Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy
por: Mouabbi, Jason A., et al.
Publicado: (2023)

Outcomes of Women Undergoing Mastectomy for Unilateral Breast Cancer Who Elect to Undergo Contralateral Mastectomy for Symmetry: A Systematic Review
por: Griffin, Cora, et al.
Publicado: (2023)

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
por: Barcenas, Carlos H., et al.
Publicado: (2021)

Effectiveness of Prophylactic Mastectomy
por: Berkeš, Andrej, et al.
Publicado: (2023)

Plastic and Reconstructive Surgeons' Knowledge and Comfort of Contralateral Prophylactic Mastectomy: A Survey of the American Society of Plastic Surgeons
por: Lopez, Christopher D., et al.
Publicado: (2019)

Factors associated with contralateral preventive mastectomy
por: Yakoub, Danny, et al.
Publicado: (2015)

Perceptions of Prophylactic Mastectomy in Korea
por: Yoon, Han Young, et al.
Publicado: (2016)

Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks
por: Boughey, Judy C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hjr8sch1s0l1hg8g52dunfm5j1